Intra cellular therapies inc

Major-Pharmaceuticals

ITCI


430 East 29th Street
New York , NY 10016

Executive/
Director

Price

  • Last Close
  • $ 83.8
    $ -0.44 -0.52 %
    Jan 3, 2025
  • 52-Week High/Low
  • $79.03 - $46.37
  • YTD
  • 0.3%

  • Trading Volume
  • 9,330
  • Market Cap Full
  • $ 8.1B
  • Shares Outstanding
  • 96.2M
    Oct 31, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 -48.3% 7.7% 45.4% 6.9% -5% 6.7% 17% 2.3% -3.5% 0.3%
Q2 39.6% -23.6% -8.8% 9.2% 4% 20.3% -6.8% 16.9% 3.9% -
Q3 -60.7% 27.1% 22.1% -48.1% 8% -10.8% -18.5% -17.7% -8.6% -
Q4 -1% -6.6% -45.7% 372.8% 23.9% 43.7% 13.7% 36.5% -6.6% -
J F M A M J J A S O N D
2025 0.3% - - - - - - - - - - -
2024 -6% 3.2% -0.6% 4.6% -6.9% 5.3% 11.1% -8.6% - - - -2.4%
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    205%-72%-4%-21%203%-8%65%1%35%17%0%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.64 0.62 -0.65 -0.63 -0.73 -0.65 -0.78 -0.46
Q2 0.71 0.41 -0.68 -0.68 -0.96 -0.85 -0.92 -0.45
Q3 0.70 0.53 -0.76 -0.63 -0.79 -0.95 -0.57 -0.25
Q4 0.64 0.56 -0.75 -0.74 -0.75 -1.05 -0.45 -
A 2.7 2.1 -2.8 -2.7 -3.2 -3.5 -2.7 -1.16

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 55.1 66.1 80.9 93.6 95.3
Jun 54.7 55.1 66.5 81.2 94.3 95.9
Sep 54.7 55.2 67.3 81.3 94.4 96.1
Dec 54.7 55.3 80.2 81.5 94.7 96.2

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 0.8 1 0.3 - -
Fixed Asset Turnover 125 42 11.5 - -
Total Asset Turnover 0.3 0.2 - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 33 143 57.8 25.7 23.1
Equity multiplier - - - - -